Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-10-15
1988-08-09
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548188, C07D27734, A61K 31425
Patent
active
047628499
ABSTRACT:
Novel alkanoylthiazolones enhance myocardial contractile force and are useful as cardiotonics in the treatment of heart failure.
REFERENCES:
patent: 3514465 (1970-05-01), Posselt et al.
patent: 3948925 (1976-04-01), Perronnet et al.
patent: 4405635 (1983-09-01), Schnettler
patent: 4405638 (1983-09-01), Cavazza
patent: 4623651 (1986-11-01), Grisar et al.
Y. Yamamoto, J. Pharm. Soc. Japan 72, 1020, (1952), Abstracted at Chemical Abstracts, vol. 46, cols. 10285-10286.
R. A. Schnettler, 4-Substituted-1,3-Dihydro-2H-Imidazol-2-ones, 187th American Chemical Society National Meeting, Apr. 8-13, 1984.
E. Ochiai, J. Pharm. Soc. Japan, 60, 164, (1940), Abstracted at Chemical Abstracts, vol. 34, cols. 3449-3450.
Dage Richard C.
Grisar J. Martin
Schnettler Richard A.
Gerstl Robert
McDonald Raymond A.
Merrell Dow Pharmaceuticals Inc.
LandOfFree
Cardiotonic alkanoylthiazolones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardiotonic alkanoylthiazolones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiotonic alkanoylthiazolones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-918865